Computational analysis of the interaction between ligand-receptor pairs

Current Pharmaceutical Design

Volumn 14, Issue 6, 2008, Pages 588-592

  Jiang, Zhenran ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Binding energy; Chemokine receptors; Co evolution; Ligand receptor pair

Indexed keywords

CHEMOKINE RECEPTOR; LIGAND; MEMBRANE RECEPTOR;

ANALYTIC METHOD; BINDING AFFINITY; BINDING KINETICS; BIOINFORMATICS; COEVOLUTION; COMPUTER MODEL; ENERGY; EVOLUTIONARY ALGORITHM; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG INTERACTIONS; HUMANS; LIGANDS; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 42049085509     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783885326     Document Type: Review

References (72)

1. Bell GI. Models for the specific adhesion of cells to cells. Science 1978; 200: 618-627.
2. Coombs D, Dembo M, Wofsy C, Goldstein B. Equilibrium thermodynamics of cell-cell adhesion mediated by multiple ligand-receptor pairs. Biophys J 2004; 86(3): 1408-1423.
3. Zhang R, Tan Z, Liang P. Identification of a novel ligand-receptor pair constitaively activated by ras oncogenes. J Biol Chem 2000; 275: 24436-43.
4. Szleifer I. Ligand-receptor binding in the presence of polymeric spacers. American Physical Society, APS March Meeting, March 5-9, 2007.
5. Bongrand P. Ligand receptor interaction. Rep Prog Phys 1999; 62: 921-968.
6. Bonig H, Priestley GV, Papayannopoulou T. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood 2006; 107: 79-86.
7. Schwimmer LJ, Rohatgi P, Azizi B, Seley KL, Doyle DF. Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules. Proc Natl Acad Sci USA 2004; 101: 14707-14712.
8. Moyle WR, Campbell RK, Myers RV, Bernard MF, Han Y, Wang X. Co-evolution of ligand-receptor pairs. Nature 1994; 368: 251-255.
9. Fryxell KJ. The co-evolution of gene family trees. Trends Genet 1996; 12: 364-369.
10. van Kesteren RE, Tensen CP, Smit AB, van Minnen J, Kolakowski LF, Meyerhof W, et al. Co-evolution of ligand-receptor pairs in the vasopressin/oxytocin superfamily of bioactive peptides. J Biol Chem 1996; 271:3619-26.
11. Goh C, Cohen F. Co-evolutionary analysis reveals insights intoprotein-protein interactions. J Mol Biol 2002; 324:177-192.
12. Pazos F, Valencia A. In silico two-hybrid system for the selection of physically interacting protein pairs. Proteins 2002; 47:219-227.
13. Cardoso JC, Vieira FA, Gomes AS, Power DM. PACAP, VIP and their receptors in the metazoa: Insights about the origin and evolution of the ligand-receptor pair, Peptides 2007; 28:1902-1919.
14. Goh CS, Bogan AA, Joachimiak M, Walther D, Cohen FE. Co-evolution of proteins with their interaction partners. J Mo Biol 2000; 299: 283-293.
15. Bafna V, Hannenhalli S, Rice K, Vawter L. Ligand-receptor pairing via tree comparison. J Comput Biol 2000; 7: 59-70.
16. Kim WK, Bolser DM, Park JH. Large-scale co-evolution analysis of protein structural interlogues using the global protein structural interactome map (PSIMAP). Bioinformatics 2004; 20: 1138-1150.
17. Gertz J, Elfond G, Shustrova A, Weisinger M, Pellegrini M, Cokus S et al. Inferring protein interactions from phylogenetic distance matrices, Bioinformatics 2003; 19:2039-2045.
18. Yoshie O, Imai T, Nomiyama, H. Chemokines in immunity. Adv Immunol 2001; 78: 57-110.
19. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
20. D'Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: An overview. J Immunol Methods 2003; 273: 3-13.
21. Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: The key to inflammation? Ann Rheum Dis 2004; 63: 1186-94.
22. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4:540-50.
23. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
24. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor- 1/CXCL12-CXC chemokine receptor 4 biological axis in nonsmall cell lung cancer metastases. Am J Respir Crit Care Med 2003; 167(12):1676-1686.
25. Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA, et al. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol 2002; 3:3531-3517.
26. Graeber TG, Eisenberg D. Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat Genet 2001; 29: 295-300.
27. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003; 14:409-426.
28. Juarez J, Bendall L, Bradstock K. Chemokines and their receptors as therapeutic targets: The role of the SDF-1/CXCR4 axis. Curr Pharm Des 2004; 10(11):1245-59.
29. Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, et al. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: A possible predictor of metastasis. Bioch and Biophy Res 2004; 320(4):656-63.
30. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-682.
31. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-12690.
32. Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA, Christofidou-Solomidou M, et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohemato-poietic cells. Stem Cells 2001; 19:453-66.
33. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002; 62:5930-5938.
34. Bin LH, Nielson LD, Liu X, Mason RJ, Shu HB. Identification of uteroglobin-related protein 1 and macrophage receptor with collagenous structure as a lung-specific ligand-receptor pair. J Immunol 2003; 171: 924-930.
35. Harrison JK, Luo D, Streit WJ. In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system. Methods 2003; 29(4): 312-8.
36. Benelli R, Lorusso G, Albini A, Noonan DM. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 2006; 12(24):3101-15.
37. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-79.
38. Luker KE, Luker GD. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 2006; 238(1):30-41.
39. Allavena P, Marchesi F, Mantovani A. The role of chemokines and their receptors in tumor progression and invasion: Potential new targets of biological therapy. Curr Cancer Ther Rev 2005; 12:81-92.
40. Rollins BJ. Release the hounds! A chemokine elicits monocytes from bone marrow. Nat Immunol 2006; 7(3):230-2.
41. Rubie C, Frick VO, Wagner M, Weber C, Kruse B, Kempf K, et al. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 2006; 12(41): 6627-6633.
42. Zacharias M. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to KBP. Proteins 2004; 54:759-767.
43. Rajarathnam K, Designing decoys for chemokine-chemokine receptor interaction. Curr Pharm Des 2002; 8: 2159-2169.
44. Jeppesen C, Wong JY, Kuhl TL, Israelachvili JN, Mullah N, Zalipsky S, et al. Impact of polymer tether length on multiple ligand-receptor bond formation. Science 2001; 20: 465-468.
45. Ajay Murcko MA. Computational methods to predict binding free energy in ligand-receptor complexes. J Med Chem 1995; 38: 4953-4967.
46. Vakser IA. Long-distance potentials: An approach to the multiple-minima problem in ligand-receptor interaction. Protein Engineering, Protein Eng 1996; 9(1):37-41.
47. Dolenc J, Oostenbrink C, Koller J, van Gunsteren WF. Molecular dynamics simulations and free energy calculations of netropsin and distamycin binding to an AAAAA DNA binding site. Nucleic Acids Res 2005; 33:725-733.
48. Xu JR, Zhang JX, Han BC, Liang L, Ji ZL. CytoSVM: An advanced server for identification of cytokine-receptor interactions. Nucleic Acids Res 2007; 35 (Web Server issue): W538-42.
49. Andrews PR, Craik DJ, Martin JL. Computational methods to predict binding free energy in ligand-receptor complexes. J Med Chem 1995; 38(26):4953-4967.
50. Cavasotto CN, Orry AJW, Abagyan RA. The challenge of considering receptor flexibility in ligand docking and virtual screening. Curr Comput Aided Drug Des 2005; 1: 423-440.
51. Izrailev S, Stepaniants S, Balsera M, Oono Y, Schulten K. Molecular dynamics study of unbinding of the avidin-biotin complex. Biophys J 1997; 72(4): 1568-1581.
52. Bock JR, Gough DA. A aew method to estimate ligand-receptor energetics. Mol Cell Proteomics 2002; 1(11): 904-10.
53. Hayashi Y, Sakaguchi K, Kobayashi M, Kobayashi M, Kikuchi Y, Ichiishi E. Molecular evaluation using in silico protein interaction profiles. Bioinformatics 2003, 19(12):1514-1523.
54. Mac Gabhann F, Popel AS. Differential binding of VEGF isoforms to VEGF receptor in the presence of neuropilin-1: A computational model. Am J Physiol Heart Circ Physiol 2005; 288: 2851-2860.
55. Chockalingam K, Chen Z, Katzenellenbogen JA, Zhao H. Directed evolution of specific receptor-ligand pairs to use in the creation of gene switches. Proc Natl Acad Sci USA 2005; 102: 5691-6.
56. Tan SH, Zhang Z, Ng SK. ADVICE: Web service for automated detection and validation of interaction by co-evolution. Nucleic Acids Res 2004; 32: W69-72.
57. Sato T, Yamanishi Y, Kanehisa M, Toh H. The inference of protein-protein interactions by co-evolationary analysis is improved by excluding phylogenetic relationsbips. Bioinformatics 2005; 21:3482-3489.
58. Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, et al. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration. Blood 2005; 105: 2963-2969.
59. Laurie AT, Jackson RM. Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 2005; 21: 1908-1916.
60. Florin EL, Moy VT, Gaub HE. Adhesion forces between individual ligand-receptor pairs. Science 1994; 264: 415.
61. Rosenkilde MM, Andersen MB, Nygaard R, Frimurer TM, Schwartz TW. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI. Mol Pharmacol 2007; 71:930-941.
62. Lindahl E, Delarue M. Docking refinement using low frequency normal mode amplitude optimization. Nucleic Acids Res 2005; 33:4496-4506.
63. Koh JT. Engineering selectivity and discrimination into ligand-receptor interfaces. Chem Biol 2002; 9: 17-23.
64. Yuryev A, Mulyukov Z, Kotelnikova E, Maslov S, Egorov S, Nikitin A, et al. Automatic pathway building in biological association networks. BMC Bioinformatics 2006; 7: 171.
65. Ponting CP, Russell RR. The natural history of protein domains. Annu Rev Biophys Biomol Struct 2002; 31:45-71.
66. Sprinzak E, Margalit H. Correlated sequence-signatures as markers of protein-protein interaction. J Mol Biol 2001; 311;681-692.
67. Deng M, Mehta S, Sun F, C.hen T. Inferring domain-domain interactions from protein-protein interactions. Genome Res 2002; 12: 1540-1548.
68. Li H, Li J. Discovery of stable and significant binding motif pairs from PDB complexes and protein interaction datasets. Bioinformatics 20005; 21(3): 314-324.
69. Buck E, Iyengar, R. Organization and functions of interacting domains for signaling by protein-protein interactions. Sci STKE 2003; 18: Re14.
70. Bryan J, Crane A, Vila-Carriles WH, Babenko AP, Aguilar-Bryan L. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels. Curr Pharm Des 2005; 11(21): 2699-716.
71. Panaro MA, Acquafredda A, Sisto M, Lisi S, Saccia M, Mitolo V. Evolution of a "conserved" amino acid sequence: A model study of an in silico investigation of the phylogenesis of some immune receptors. Curr Pharm Des 2006; 12(32): 4091-121.
72. Shi L, Javitch JA. A role for information collection, management, and integration in structure-function studies of G-protein coupled receptors. Curr Pharm Des 2006; 12(14): 1771-83.